SeaStar Medical Holding Corp

Name: SeaStar Medical Holding Corp standardized financial statements, quarterly
Creator: Listed

ICUNasdaqCIK 1831868HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$615.0k, Q2 FY2026

Operating income−$3.8m, Q2 FY2026

Net income−$3.7m, Q2 FY2026

SeaStar Medical Holding Corp, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.4	0.5	0.6
Cost of revenue	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Gross profit	$m	not reported	not reported	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.4	0.4	0.6
Research and development	$m	1.1	1.2	1.7	2.3	2.3	2.7	2.4	1.0	1.9	2.2	2.3	2.5
Operating income	$m	(2.9)	(2.9)	(4.0)	(4.7)	(4.5)	(4.8)	(3.8)	(1.8)	(3.6)	(3.0)	(3.6)	(3.8)
Interest expense	$m	0.2	0.2	0.1	0.1	0.3	(0.3)	0.0	0.0	0.0	0.0	0.0	0.0
Income tax	$m	0.0	(0.0)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$m	(7.2)	(9.5)	(12.7)	(3.2)	(4.5)	(4.4)	(3.8)	(2.0)	(3.5)	(2.9)	(3.5)	(3.7)
Diluted EPS	$ per share	(9.02)	not reported	(4.73)	(1.03)	(1.10)	not reported	(0.44)	(0.18)	not reported	not reported	not reported	not reported
Basic EPS	$ per share	(9.02)	not reported	(4.73)	(1.03)	(1.10)	not reported	(4.38)	(1.77)	(0.13)	not reported	(0.90)	(0.91)

Balance sheet

Cash and equivalents$7.0m, Q2 FY2026

Long-term debt$0, Q3 FY2024

Shareholders' equity$4.3m, Q2 FY2026

SeaStar Medical Holding Corp, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.1	0.2	5.0	1.2	2.1	1.8	5.3	6.3	13.8	12.0	9.3	7.0
Current assets	$m	1.2	2.3	6.5	2.4	3.6	3.8	6.8	7.6	14.9	13.6	10.8	8.2
Total assets	$m	2.5	3.5	7.7	3.5	4.6	4.7	14.2	8.4	15.5	14.2	11.3	8.6
Current liabilities	$m	12.8	13.0	9.6	9.9	6.6	6.8	7.0	5.0	4.1	3.7	3.9	4.4
Total liabilities	$m	18.5	17.4	12.2	10.4	6.6	6.8	7.0	5.0	4.1	3.7	3.9	4.4
Long-term debt	$m	5.7	4.1	1.1	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	0.6	not reported	not reported	not reported	0.6	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	(16.0)	(13.9)	(4.5)	(6.9)	(0.0)	(2.2)	0.6	3.3	11.5	10.4	7.3	4.3

Cash flow

Operating cash flow−$3.0m, Q2 FY2026

SeaStar Medical Holding Corp, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,337)	(4,485)	(3,488)	(2,824)	(5,002)	(4,693)	(2,654)	(3,007)	(3,844)	(4,094)	(2,761)	(2,994)

Diluted shares (weighted)11.33m, Q2 FY2025

SeaStar Medical Holding Corp, shares, quarterly
Line item	Unit	Q2 FY20212021-06-30	Q1 FY20222022-03-31	Q2 FY20222022-06-30	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30
Diluted shares (weighted)	m shares	13.0	7.2	7.2	7.2	13.0	0.6	0.8	2.7	3.2	4.1	8.6	11.3

Shares outstanding: 4.41m at Aug 5, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.